Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 11,176–11,200 of 27,380 studies, newest first · page 448 of 1096.

September 2020 25

  1. 2020-09-22

    APOE ε4 and resting-state functional connectivity in racially/ethnically diverse older adults

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Compared to APOE ε4 non-carriers, APOE ε4 carriers had lower rsFC in temporal DMN, but only in non-Hispanic Whites. +2 more findings

  2. 2020-09-22

    Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Despite challenges, current literature and practice support implementation of telemedicine assessments for patients with cognitive impairment.

  3. 2020-09-22

    Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease

    ✓ Peer-reviewed Digital health tools Molecular neurodegeneration

    Key finding: With the advent of advanced neuroimaging techniques, such as positron emission tomography (PET) and magnetic resonance imaging (MRI), accumulating evidence has revealed structural and functional brain alterations related to the symptoms of SCD. +2 more findings

  4. 2020-09-21

    Impact of COVID-19 related social support service closures on people with dementia and unpaid carers: a qualitative study

    ✓ Peer-reviewed Caregiving Aging & mental health

    Key finding: PLWD and carers need to receive specific practical and psychological support during the pandemic to support their well-being, which is severely affected by public health restrictions. +1 more finding

  5. 2020-09-21

    Supervised Digital Neuropsychological Tests for Cognitive Decline in Older Adults: Usability and Clinical Validity Study

    ✓ Peer-reviewed Cognitive tests and assessment JMIR mHealth and uHealth

    Key finding: The positive results pave the way for the deployment of the system to a nonsupervised environment, thus representing a potential efficacious and ecological solution to support clinicians in the identification of early signs of cognitive decline. +2 more findings

  6. 2020-09-21

    Klotho overexpression improves amyloid-β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Aging cell

    Key finding: The upregulation of Klotho levels in the brain and serum significantly ameliorated Aβ burden, neuronal and synaptic loss and cognitive deficits in aged APP/PS1 mice. +3 more findings

  7. 2020-09-21

    COVID‐19 Pandemic in Assisted Living Communities: Results from Seven States

    ✓ Peer-reviewed Risk factors Journal of the American Geriatrics Society

    Key finding: State case fatality ranged from 3.32% in North Carolina to 9.26% in Connecticut, but for ALs in these states it was 12.89% and 31.59%, respectively. +4 more findings

  8. 2020-09-21

    β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer's disease pathology

    ✓ Peer-reviewed Brain tissue and pathology Journal of neuroinflammation

    Key finding: Recent studies suggest that AD pathology is driven by age-related changes in metabolism. +3 more findings

  9. 2020-09-21

    Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model

    ✓ Peer-reviewed Digital health tools International journal of molecular sciences

    Key finding: We observed increased levels of all biomarkers except Aβ40 in the AD group when compared to the MCI and controls. +3 more findings

  10. 2020-09-21

    Brain Functional Magnetic Resonance Imaging Highlights Altered Connections and Functional Networks in Patients With Hypertension

    ✓ Peer-reviewed Brain scans and imaging Hypertension (Dallas, Tex. : 1979)

    Key finding: Here, we used resting-state functional magnetic resonance imaging to explore brain functional-hemodynamic coupling across different regions and their connectivity in patients with hypertension, as compared to subjects with normotension. +2 more findings

  11. 2020-09-21

    Bayesian Genome-wide TWAS Method to Leverage both cis- and trans-eQTL Information through Summary Statistics

    ✓ Peer-reviewed Genetics American journal of human genetics

    Key finding: Our simulation studies illustrated that BGW-TWASs achieved higher power compared to existing TWAS methods that do not assess trans-eQTL information. +3 more findings

  12. 2020-09-20

    Subjective Cognitive Decline, Cognitive Reserve Indicators, and the Incidence of Dementia

    ✓ Peer-reviewed Risk factors Journal of the American Medical Directors Association

    Key finding: Baseline subjective cognitive decline and low cognitive reserve significantly increased the risk of dementia, after 2 years of follow-up. +4 more findings

  13. 2020-09-20

    Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's International journal of molecular sciences

    Key finding: There is increasing evidence that the neuropathological events associated with AD are interrelated and that many of them not only are implicated in the onset of this pathology but are also a consequence of other alterations.

  14. 2020-09-20

    Benefits of exercise training on cerebrovascular and cognitive function in ageing

    ✓ Peer-reviewed Prevention and risk Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

    Key finding: Modifiable lifestyle factors that cause a decline in cardiometabolic health, such as physical inactivity, exacerbate these changes beyond those that are associated with normal ageing. +1 more finding

  15. 2020-09-18

    Tooth Loss and Dementia: A Critical Examination

    ✓ Peer-reviewed Risk factors Journal of dental research

    Key finding: People with better childhood cognitive function have better oral health and access to routine dental care as they go through life, losing fewer teeth along the life course. +4 more findings

  16. 2020-09-18

    The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease

    ✓ Peer-reviewed Brain tissue and pathology Frontiers in neurology

    Key finding: AD affects the health of millions of people in the United States and worldwide. +3 more findings

  17. 2020-09-18

    Interrelations of Alzheimer´s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation

    ✓ Peer-reviewed Tau biomarkers Journal of neurochemistry

    Key finding: To test this hypothesis, we investigated three AD candidate markers (ferritin, fatty acid binding protein 3 (FABP-3), and neurogranin) in interrelation to established AD and inflammatory protein markers. +3 more findings

  18. 2020-09-18

    Accurate Blood-Based Diagnostic Biosignatures for Alzheimer's Disease via Automated Machine Learning

    ✓ Peer-reviewed Digital health tools Journal of clinical medicine

    Key finding: In conclusion, using the automated machine learning tool JADBIO, we produced accurate predictive biosignatures extrapolating available low sample -omics data. +1 more finding

  19. 2020-09-16

    Interaction between genetic factors, Porphyromonas gingivalis and microglia to promote Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Journal of oral microbiology

    Key finding: In late-onset Alzheimer disease (AD) pathogenesis, genes, infections and immunity could be significant factors. +1 more finding

  20. 2020-09-16

    Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues

    ✓ Peer-reviewed Prevention trials The Lancet. Neurology

    Key finding: Neuropsychological research suggests that cognitive processing speed and episodic memory are the most frequently affected cognitive domains.

  21. 2020-09-16

    Drug repositioning and repurposing for Alzheimer disease

    ✓ Peer-reviewed Inflammation and the immune system Nature reviews. Neurology

    Key finding: Transcriptional profiling offers a new and highly efficient approach to the identification of novel candidates for repositioning and repurposing. +3 more findings

  22. 2020-09-15

    Are family carers part of the care team providing end-of-life care? A qualitative interview study on the collaboration between family and professional carers

    ✓ Peer-reviewed End-of-life care Palliative medicine

    Key finding: This qualitative study about the experiences and perceptions of family carers of people with a chronic life-limiting illness living at home regarding the collaboration with different healthcare providers in the last phase life, showed that family carers experience a lot of possibilities, but perceive missed opportunities as well, for healthcare professionals to effectively collaborate with them for palliative care. +1 more finding

  23. 2020-09-15

    Alzheimer's disease: Recent treatment strategies

    ✓ Peer-reviewed Drug development European journal of pharmacology

    Key finding: Current treatment for AD (donepezil, galantamine, rivastigmine and memantine) is only symptomatic and has modest benefits. +3 more findings

  24. 2020-09-14

    A phase II randomized trial of sodium oligomannate in Alzheimer's dementia

    ✓ Peer-reviewed Clinical trials Alzheimer's research & therapy

    Key finding: Comparing with the placebo group (n = 83, change - 1.45), the ADAS-cog12 score change in the GV-971 600-mg group (n = 76) was - 1.39 (p = 0.89) and the GV-971 900-mg group (n = 83) was - 2.58 (p = 0.30). +4 more findings

  25. 2020-09-13

    Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: NfL had a stronger association than t-tau with clinical scales; t-tau did not hold additional information to that given by NfL (P > 0.05 at all time points). +4 more findings

Browse the library by subject, with the full score breakdown →